Inventor
GURNEY AUSTIN
US42 patents
⚠️ This page may combine multiple inventors who share the name “GURNEY AUSTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
18 patentsUS6579520B2Jun 17, 2003
IL-17 related mammalian cytokine polypeptides (IL-17E)
GENENTECH INC76 citations97
US6569645B2May 27, 2003
IL-17 homologous polypeptides and therapeutic uses thereof
GENENTECH INC89 citations97
US7115398B2Oct 3, 2006
IL-17 homologous polypeptides and therapeutic uses thereof
GENENTECH INC38 citations96
US7256264B2Aug 14, 2007
Receptor for IL-17 homologous polypeptides and uses thereof
GENENTECH INC38 citations95
US7074592B2Jul 11, 2006
Secreted and transmembrane polypeptides nucleic acid encoding
GENENTECH INC29 citations93
US7217412B2May 15, 2007
IL-17C related mammalian cytokine polypeptides
GENENTECH INC32 citations92
US7303896B2Dec 4, 2007
Nucleic acid encoding novel type-1 cytokine receptor GLM-R
GENENTECH INC38 citations91
US7193049B2Mar 20, 2007
PRO862 polypeptides
GENENTECH INC3 citations82
US7414112B2Aug 19, 2008
Antibodies to PRO1550 polypeptides
GENENTECH INC6 citations74
US6413770B1Jul 2, 2002
NL4 tie ligand homologue nucleic acid
GENENTECH INC7 citations73
US6136569AOct 24, 2000
Method of creating a cDNA library enriched in signal sequences
GENENTECH INC8 citations73
US6060249AMay 9, 2000
Method of selection for genes encoding secreted and transmembrane proteins
GENENTECH INC10 citations73
US7550573B2Jun 23, 2009
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC1 citations63
US7718397B2May 18, 2010
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
GENENTECH INC3 citations62
US7473763B2Jan 6, 2009
Receptor for IL-17 homologous polypeptides and uses thereof
GENENTECH INC2 citations62
US7749500B2Jul 6, 2010
Antibodies to IL-17 polypeptides and therapeutic uses thereof
GENENTECH INC0 citations52
US7452975B2Nov 18, 2008
Anti-PRO7168 antibodies
GENENTECH INC0 citations52
US7491512B2Feb 17, 2009
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
GENENTECH INC1 citations51
GURNEY AUSTIN
9 patentsUS8158758B2Apr 17, 2012
Compositions and methods for treating and diagnosing cancer
GURNEY AUSTIN35 citations96
US8628774B2Jan 14, 2014
Compositions and methods for treating and diagnosing cancer
GURNEY AUSTIN21 citations92
US8540989B2Sep 24, 2013
Compositions and methods for treating and diagnosing cancer
GURNEY AUSTIN13 citations92
US8324361B2Dec 4, 2012
Nucleic acid molecules encoding soluble frizzled (FZD) receptors
GURNEY AUSTIN11 citations92
US8088617B2Jan 3, 2012
Antibodies that bind the glutamate ligand binding region of Notch1
GURNEY AUSTIN22 citations91
US9376497B2Jun 28, 2016
Compositions and methods for diagnosing and treating cancer
GURNEY AUSTIN16 citations90
US8460661B2Jun 11, 2013
Methods of using antibodies that bind the glutamate ligand binding region of Notch1
GURNEY AUSTIN10 citations82
US9850311B2Dec 26, 2017
Compositions and methods for diagnosing and treating cancer
GURNEY AUSTIN4 citations72
US8802103B2Aug 12, 2014
Compositions and methods for diagnosing and treating cancer
GURNEY AUSTIN5 citations72
ONCOMED PHARM INC
8 patentsUS7723477B2May 25, 2010
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
ONCOMED PHARM INC40 citations96
US7750124B2Jul 6, 2010
Anti-human DLL4 antibodies and compositions
ONCOMED PHARM INC46 citations94
US8883736B2Nov 11, 2014
Compositions and methods for treating and diagnosing cancer
ONCOMED PHARM INC10 citations92
US7919092B2Apr 5, 2011
Antibodies to notch receptors
ONCOMED PHARM INC27 citations92
US8784811B2Jul 22, 2014
Method of treating cancer using antibodies to a non-ligand binding region of NOTCH1
ONCOMED PHARM INC6 citations83
US9228013B2Jan 5, 2016
Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell
ONCOMED PHARM INC3 citations73
US9732139B2Aug 15, 2017
Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptor
ONCOMED PHARM INC1 citations62
US9617340B2Apr 11, 2017
Compositions and methods for diagnosing and treating cancer
ONCOMED PHARM INC0 citations51